EUVIMEDEUVIMED entdecken
Open Access

Rest-Activity Rhythms, Their Modulators, and Brain-Clinical Correlates in Opioid Use Disorder

Rui Zhang, Peter Manza, Sukru Baris Demiral, Dardo Tomasi, Michele-Vera Yonga, Weizheng Yan, Ehsan Shokri-Kojori, Melanie Schwandt, Leah Vines, Diana Sotelo, Christina Lildharrie, Esther Lin und 3 weitere

JAMA Network Open · 2025

DOI: 10.1001/jamanetworkopen.2024.57976 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, 2025. Verfasst von Rui Zhang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland. Hauptthemen laut MEDLINE: Opioid-Related Disorders, Rest, Brain, Circadian Rhythm. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAAA NIH HHS, Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Sleep and circadian disruptions are highly prevalent in opioid use disorder (OUD) and are a barrier to successful treatment and recovery; yet few objective data are available, especially for individuals in OUD treatment with opioid agonist therapy. If disruptions remain present despite OUD treatment, this information would yield potential new targets for adjunctive therapy.

Objective

To systematically investigate different aspects of rest-activity rhythms (RAR), including sleep, physical activity, circadian rhythmicity, and brain functional correlates in individuals with OUD. Design, Setting, and Participants This cross-sectional study conducted from October 12, 2017, through January 11, 2024, recruited participants with OUD from treatment programs or the community in the District of Columbia, Maryland, and Virginia area. Participants included individuals with OUD treated with methadone or buprenorphine, individuals with OUD who remained abstinent without medications, and healthy controls (HCs). Healthy participants were recruited from advertisements. Statistical analyses were conducted between March 1 and May 31, 2024. Main Outcomes and Measures In total, 21 RAR features were derived from 1-week actigraphy data, and principal components were used to extract independent RAR components. Modulators and brain and clinical correlates of RAR were also examined.

Results

This study included 73 participants (46 [63%] male; mean [SD] age, 43.5 [11.3] years). Among 42 patients with OUD (16 [38%] female; mean [SD] age, 42.7 [11.4] years), 33 receiving medications for opioid use disorder (MOUD) exhibited greater sleep-wake irregularity than 9 patients without MOUD (mean difference, 0.85 [95% CI, 0.00-1.69]) or 31 age- and sex-matched HCs (11 [36%] female; mean [SD] age, 44.5 [11.3] years; mean difference, 0.75 [95% CI, 0.19-1.31). Among participants receiving MOUD, greater sleep irregularity was associated with longer heroin use history ( r 26 = 0.45; P = .02) and lower daytime light exposure ( r 33 = −0.57; P < .001). Compared with HCs, participants with OUD exhibited lower fractional occupancy (percentage of occurrence) in a default mode network–dominated brain state, with individuals experiencing more pronounced sleep-wake irregularities displaying exacerbated impairments ( r 23 = −0.55; P = .007). Conclusions and Relevance Findings of this cross-sectional study showed that sleep irregularity in participants with OUD receiving opioid agonist medications correlated with years of opioid misuse and shorter daylight exposures and was associated with impaired brain state dynamics. These findings suggest that interventions increasing light exposure may improve sleep-wake irregularity and brain functional network dynamics in individuals with OUD receiving opioid agonist medications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Opioid-Related DisordersRestBrainCircadian RhythmExerciseHumansMaleFemaleCross-Sectional StudiesAdultMiddle AgedOpiate Substitution TreatmentSleepActigraphyMethadoneBuprenorphineAnalgesics, Opioid

Substanzen

MethadoneBuprenorphineAnalgesics, Opioid

Autor:innen und Institutionen

  • Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland.
  • Office of Clinical Director, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland.
  • Department of Psychiatry, University of Wisconsin, Madison.

Förderung

  • NIAAA NIH HHS
  • Intramural NIH HHS

Zitieren

APA

Zhang, R., Manza, P., Demiral, S. B., Tomasi, D., Yonga, M. V., Yan, W., Shokri-Kojori, E., Schwandt, M., Vines, L., Sotelo, D., Lildharrie, C., Lin, E., Giddens, N. T., Wang, G. J., & Volkow, N. D. (2025). Rest-Activity Rhythms, Their Modulators, and Brain-Clinical Correlates in Opioid Use Disorder. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2024.57976

Vancouver

Zhang R, Manza P, Demiral SB, Tomasi D, Yonga MV, Yan W, et al. Rest-Activity Rhythms, Their Modulators, and Brain-Clinical Correlates in Opioid Use Disorder. JAMA Network Open. 2025. doi:10.1001/jamanetworkopen.2024.57976

BibTeX
@article{Zhang2025,
  author = {Zhang, Rui and Manza, Peter and Demiral, Sukru Baris and Tomasi, Dardo and Yonga, Michele-Vera and Yan, Weizheng and Shokri-Kojori, Ehsan and Schwandt, Melanie and Vines, Leah and Sotelo, Diana and Lildharrie, Christina and Lin, Esther and Giddens, Natasha T and Wang, Gene-Jack and Volkow, Nora D},
  title = {Rest-Activity Rhythms, Their Modulators, and Brain-Clinical Correlates in Opioid Use Disorder},
  journal = {JAMA Network Open},
  year = {2025},
  doi = {10.1001/jamanetworkopen.2024.57976}
}
Kostenlos starten →